Journal of Biological Chemistry · 2011 · 88 citations · 53 references
Life SciencesGeneticsMolecular BiologyGene ExpressionMolecular OncologyOncogenesCancer Cell SignalingMorphogen SignalingOncogenic Signaling PathwaysAdenocarcinoma PathologyHippo SignalingHippo Signaling PathwayYap Signaling
Anterior Gradient Homolog 2 (AGR2) is expressed by the normal intestine and by most human adenocarcinomas, including those derived from the esophagus, pancreas, lung, breast, ovary, and prostate. Xenografts of human adenocarcinoma cell lines in nude mice previously demonstrated that AGR2 supports tumor growth. In addition, AGR2 is able to induce in vitro a transformed phenotype in fibroblast and epithelial cell lines. The mechanism underlying the growth promoting effects of AGR2 is unknown. The present study shows that AGR2 induces expression of amphiregulin (AREG), a growth promoting EGFR ligand. Induced AREG expression in adenocarcinoma cells is able to rescue the transformed phenotype that is lost when AGR2 expression is reduced. Additional experiments demonstrate that AGR2 induction of AREG is mediated by activation of the Hippo signaling pathway co-activator, YAP1. Thus AGR2 promotes growth by regulating the Hippo and EGF receptor signaling pathways.
53
Elucidation of a Universal Size-Control Mechanism in Drosophila and Mammals
Jixin Dong, Georg Feldmann, Jianbin Huang et al. · Cell · 2007 · 2.4K citations · Full text
YAP1 Increases Organ Size and Expands Undifferentiated Progenitor Cells
Fernando D. Camargo, Sumita Gokhale, Jonathan B. Johnnidis et al. · Current Biology · 2007 · 1.3K citations · Full text
The Hippo–YAP pathway in organ size control and tumorigenesis: an updated version
Bin Zhao, Li Li, Qun‐Ying Lei et al. · Genes & Development · 2010 · 1.1K citations · Full text
Second-generation shRNA libraries covering the mouse and human genomes
José M. Silva, Mamie Z. Li, Ken C. N. Chang et al. · Nature Genetics · 2005 · 619 citations